Given the intriguing observations made by Cosset and colleagues regarding the correlation between αvβ3-antagonist efficacy and GLUT3 addiction in GBM, it would be prudent to explore the transposition of these findings to the context of medulloblastoma. Here, SLC2A3 is linked to glioblastoma.